The latest financial statement is for the quarter ending 2025-09-28.
| Cash Flow | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-12-29 |
|---|---|---|---|---|
| Net loss | -53,769 | -44,266 | -23,531 | -37,452 |
| Depreciation, accretion and amortization | 9,398 | 8,829 | 8,448 | 7,544 |
| Stock-based compensation | 11,837 | 14,122 | 12,014 | 10,207 |
| Changes in fair value of common stock warrants | -1,867 | 5,885 | -15,796 | 5,115 |
| Gain on bargain purchase of assets | 0 | 4,761 | - | - |
| Impairment and loss on disposal of long-lived assets | 0 | 0 | - | 9 |
| Interest expense (non-cash) | 9,222 | - | - | - |
| Others | 93 | -926 | -479 | -274 |
| Accounts and notes receivables | 1,807 | 982 | -430 | 2,959 |
| Inventory | 1,837 | 2,584 | 2,826 | -1,900 |
| Prepaid expenses and other assets | 1,320 | 675 | -2,440 | -1,702 |
| Accounts payable | 4,298 | -2,179 | 4,420 | 2,048 |
| Accrued expenses and compensation | 2,220 | -834 | -4,167 | -159 |
| Deferred revenue | -342 | 1,501 | -457 | -2,556 |
| Deferred tax liability | -452 | -650 | -33 | 606 |
| Other liabilities | -1,014 | -191 | 1,672 | -2,237 |
| Net cash used in operating activities | -25,526 | -25,859 | -16,907 | -15,958 |
| Purchase of property and equipment | 2,973 | 7,971 | 6,272 | 16,358 |
| Payment of acquisition costs | - | - | 16 | - |
| Payment for business acquisition | 0 | 10,000 | - | 0 |
| Purchases of investments | 284,660 | 27,390 | 58,083 | 0 |
| Maturities of investments | 39,518 | 18,627 | 0 | 0 |
| Net cash provided by (used in) investing activities | -248,115 | -26,718 | -64,371 | -16,358 |
| Proceeds from issuance of convertible senior notes and loan borrowing | 360,000 | 0 | -4,572 | - |
| Payments of debt issuance costs | 9,900 | - | - | 0 |
| Proceeds from issuance of convertible senior notes and loans | - | - | - | 4,572 |
| Repayment of debt | 19 | -633 | - | - |
| Proceeds from issuance of common stock, net of issuance costs | - | - | - | 107,192 |
| Purchase of capped calls | 45,288 | - | - | 0 |
| Proceeds from exercise of common stock warrants | 232,106 | - | - | 0 |
| Payments of transaction costs related to common stock issuance | - | 0 | 512 | - |
| Payments of issuance costs related to common stock and warrant dividends | 5,995 | - | - | - |
| Repurchase of common stock | 58,385 | 0 | - | 0 |
| Proceeds from the exercise of stock options and issuance of common stock under atm, net of issuance costs | 2,351 | 0 | 782 | 486 |
| Repayment of debt | - | - | - | 209 |
| Payroll tax payments for shares withheld upon vesting of rsus | 2,002 | 1,092 | 1,761 | 1,478 |
| Proceeds from issuance of common stock under employee stock purchase plan | 0 | 711 | - | 361 |
| Repurchase of unvested restricted common stock | 0 | - | - | - |
| Net cash provided by financing activities | 473,418 | -1,194 | -1,491 | 106,532 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -307 | 126 | -228 | -2,472 |
| Change in cash, cash equivalents, and restricted cash | 199,470 | -53,645 | -82,997 | 71,744 |
| Cash and cash equivalents at beginning of period | 138,049 | 191,694 | 274,691 | 202,947 |
| Cash and cash equivalents at end of period | 337,519 | 138,049 | 191,694 | 274,691 |
Enovix Corp (ENVX)
Enovix Corp (ENVX)